NORTHCREST ASSET MANANGEMENT, LLC – Halozyme Therapeutics, Inc. Transaction History
NORTHCREST ASSET MANANGEMENT, LLC portfolio value:
$929,000
portfolio value
NORTHCREST ASSET MANANGEMENT, LLC quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -105K | $39.54 | 23.5K | |
| Q2 2022 | share | 0.00% | 0 shares | 97K | $44 | 23.5K | |
| Q1 2022 | share | Increase | +123.81% | 13K shares | 515K | $39.88 | 23.5K |
| Q4 2021 | share | Increase | 0.00% | 10.5K shares | 422K | $40.32 | 10.5K |